CHINA WEB DIRECTORY

A lot of cancer patients in the advanced stage were regarded as incurable at many hospitals. But now they have the new hope in Beijing Clinical Cancer Gene Research Center. Many patients had their disease healed or controlled here.It is the BRM intervene and release factor that brings about regenerative opportunity for cancer patients. The BRM therapy, invented by professor Wang Zeguang, is the abbreviation of biology response modifier.Through analyzing DNA in the long-term clinical trial, Wang gained both tumour-related gene and interferential gene.This brings the gene therapy into a new stage. The therapy is named "tumour gene guided-apoptosis." Tumours are comprised of unusual cells which lack certain receptors that would otherwise tell them to stop multiplying. Irregular and excessive propagation of these cells usually leads to the formation of malignant cancerous tumours. When a patient is in an advanced stage of cancer, his or her immune system may become restrained. Without the protection of immunity, he or she cannot resist the invasion of viruses and bacterium. As Wang explains, BRM therapy will impel the cancerous cell to quick apoptosis and keep it from returning.The death of cells can be caused by two different mechanisms: necrosis and apoptosis. Necrosis features turgidness, chromatic variousness, cytomembrane losing its integrality and final solution of cell. Apoptosis is a contrary dynamics concept to cell propagation. It is influenced by many complex ingredients (including genetic factor). It is a process that causes cancer cell to die on their own initiative. Because of this, it is often referred to by some medical researchers as programmed cell death (PCD) (Graphic 1). BRM intervene and release factor can directly take effect on the focus, work at cancerous cell, and make the lysosome irregularly enlarged, deformed and finally destroyed. And it will also enhance the immune system, reduce the side effect of chemotherapy and radiotherapy and keep the cancer from returning. Long-term clinical trial proves that BRM intervene and release factor is a good remedial way to the patient who failed in chemotherapy and radiotherapy or could not have operation. The clinical observations indicate that 30 per cent of the patients whose tumours completely disappeared, 30 per cent partly disappeared, 30 per cent stabilized and 10 per cent failed. Absolutely in line with the standard of World Health Organiazation(WHO),the therapy has no toxicity and no side effect. It can be orally taken and treat all kinds of cancers.

Biochemical composition and genetic Medicine